Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
melanoma
|
515 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 7 | 1997 | 2004 | ||||||
Pilomatrixoma
|
14 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.810 | 1.000 | 7 | 1999 | 2017 | ||||||
Malignant neoplasm of ovary
|
315 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 3 | 2008 | 2013 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 2 | 2014 | 2016 | ||||||
Adenocarcinoma of prostate
|
108 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adult Craniopharyngioma
|
6 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Carcinoma
|
103 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||||
Carcinoma, Basal Cell
|
91 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Childhood Craniopharyngioma
|
6 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Craniopharyngioma
|
7 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Esophageal carcinoma
|
272 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Gastric Adenocarcinoma
|
235 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Liver carcinoma
|
942 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.800 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant Uterine Corpus Neoplasm
|
152 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Medulloblastoma
|
115 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Neoplasm Metastasis
|
327 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2003 | 2003 | ||||||
Neoplasms
|
1644 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||||
ovarian neoplasm
|
757 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
Pilomatrix carcinoma of skin
|
3 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Stomach Neoplasms
|
55 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
Supratentorial Embryonal Tumor, Not Otherwise Specified
|
4 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||||
Transitional cell carcinoma of bladder
|
158 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Uterine Cervical Neoplasm
|
72 | 0.683 | 0.240 | 3 | 41224622 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 |